Neurocrine Biosciences

Neurocrine Wins FDA Approval For Genetic Disorder Drug
MSN/Investors Business Daily
Sun, 12/15/24 - 10:43 pm
Neurocrine Biosciences
FDA
Crenessity
CAH
Neurocrine's bid to save schizophrenia prospect fails
Fierce Biotech
Fri, 09/13/24 - 11:14 am
Neurocrine Biosciences
schizophrenia
clinical trials
luvadaxistat
Neurocrine's drug cuts schizophrenia symptoms in mid-stage study
Reuters
Wed, 08/28/24 - 11:42 am
Neurocrine Biosciences
schizophrenia
clinical trials
NBI-1117568
Neurocrine Biosciences' Huntington's disease drug gets FDA approval
Reuters
Tue, 04/30/24 - 06:27 pm
Neurocrine Biosciences
FDA
Ingrezza
Huntington's disease
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail
Fierce Biotech
Tue, 04/23/24 - 09:42 pm
Neurocrine Biosciences
clinical trials
Takeda
major depressive disorder
Savitri
Neurocrine’s hopes for hyperplasia blockbuster a step closer after phase 3 win
Fierce Biotech
Tue, 09/12/23 - 10:47 am
Neurocrine Biosciences
crinecerfont
clinical trials
congenital adrenal hyperplasia
Top biotech licensing deals of Q1 2023
BioSpace
Thu, 03/30/23 - 11:03 am
biotech
licensing
Moderna Therapeutics
CytomX
Voyager Therapeutics
Neurocrine Biosciences
Kronos Bio
Genentech
Karuna Therapeutics
Goldfinch Bio
Neurocrine randomizes first patient in Phase II schizophrenia therapy trial
Clinical Trials Arena
Fri, 10/28/22 - 10:28 am
Neurocrine Biosciences
clinical trials
NBI-1117568
schizophrenia
Sometimes, Clinical Trials Miss the Mark: Neurocrine, Akebia, Eliem and Athira
BioSpace
Fri, 08/5/22 - 10:57 am
clinical trials
Neurocrine Biosciences
Akebia Therapeutics
Eliem Therapeutics
Athira Pharma
‘A negative trial, not a failed trial’: Neurocrine axes in-licensed tremor program on phase 2 data
Fierce Biotech
Fri, 08/5/22 - 10:44 am
Neurocrine Biosciences
NBI-827104
clinical trials
essential tremor
Why Neurocrine Biosciences Shares Fell Nearly 10% Today
Motley Fool
Tue, 11/2/21 - 11:49 pm
Neurocrine Biosciences
earnings
Neurocrine raises a new monument to mental health in pandemic resilience campaign
Fierce Pharma
Fri, 10/8/21 - 10:53 am
mental health
Neurocrine Biosciences
pandemic
Neurocrine launches Parkinson's therapy as COVID-19 related disruptions ease
Yahoo/Reuters
Mon, 09/14/20 - 10:18 am
Neurocrine Biosciences
drug launches
Parkinson's Disease
pandemic
COVID-19
Ogentys
How Neurocrine Biosciences Crushed It in Q2
Motley Fool
Tue, 08/4/20 - 11:08 am
Neurocrine Biosciences
earnings
Takeda Grants License To Neurocrine Biosciences For Seven Pipeline Programs
NASDAQ
Tue, 06/16/20 - 10:48 am
Takeda
Neurocrine Biosciences
psychiatry
schizophrenia
treatment-resistant depression
anhedonia
How Neurocrine Biosciences Crushed It in Q4
Motley Fool
Wed, 02/5/20 - 10:05 am
Neurocrine Biosciences
earnings
Neurocrine signs $400M-plus deal with Idorsia for epilepsy drug
Pharmaforum
Fri, 01/10/20 - 10:23 am
Idorsia
Neurocrine Biosciences
epilepsy
pediatric epilepsy
ACT-709478
Why Earnings Season Could Be Great for Neurocrine Biosciences (NBIX)
Yahoo/Zacks.com
Sat, 11/2/19 - 07:49 pm
Neurocrine Biosciences
earnings
Neurocrine Biosciences Posts Sizzling Sales Growth in Q2
Motley Fool
Tue, 07/30/19 - 07:58 am
Neurocrine Biosciences
earnings
FDA Accepts Neurocrine's NDA for Parkinson's Disease Drug
Yahoo/Zacks.com
Fri, 07/12/19 - 09:45 am
Neurocrine Biosciences
FDA
Parkinson's Disease
opicapone

Pages